- Male sex
- Increasing age
- Smoking
- Exposures to benzene, aromatic amines, carcinogens, chemotherapy, or high doses of analgesics
- A history of:
- irritative voiding symptoms
- chronic urinary tract infection
- indwelling urinary catheter
- pelvic irradiation.
Summary
Citations
European Association of Urology. EAU guidelines on urological trauma. Mar 2025 [internet publication].[Full Text]
American Urological Association. Urotrauma (2020). Apr 2020 [internet publication].[Full Text]
Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016 Apr 5;164(7):488-97.[Abstract][Full Text]
American College of Radiology. ACR appropriateness criteria: hematuria. 2019 [internet publication].[Full Text]
1. Takeuchi M, McDonald JS, Takahashi N, et al. Cancer prevalence and risk stratification in adults presenting with hematuria: a population-based cohort study. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):308-19.[Abstract][Full Text]
2. Rai BP, Luis Dominguez Escrig J, Vale L, et al. Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria. Eur Urol. 2022 Aug;82(2):182-92.[Abstract]
3. Edwards TJ, Dickinson AJ, Natale S, et al. A prospective analysis of the diagnostic yield resulting from 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006 Feb;97(2):301-5.[Abstract]
4. Buntinx F, Wauters H. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. Fam Pract. 1997 Feb;14(1):63-8.[Abstract][Full Text]
5. Bruyninckx R, Buntinx F, Aertgeerts B, et al. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract. 2003 Jan;53(486):31-5.[Abstract][Full Text]
6. Dulku G, Shivananda A, Chakera A, et al. Painless visible haematuria in adults: an algorithmic approach guiding management. Cureus. 2019 Nov 13;11(11):e6140.[Abstract][Full Text]
7. Lucca I, Klatte T, Fajkovic H, et al. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol. 2015 Oct;12(10):585-92.[Abstract]
8. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. May 2025 [internet publication].[Full Text]
9. Barnes H, Holland AE, Westall GP, et al. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst Rev. 2018 Jan 3;(1):CD010908.[Abstract][Full Text]
10. Mukhtar S, Woodhouse C. The management of cyclophosphamide-induced haematuria. BJU Int. 2010 Apr;105(7):908-12.[Abstract]
11. Powles T, Bellmunt J, Comperat E, et al. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022 Mar;33(3):244-58.[Abstract][Full Text]
12. Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 Update. Eur Urol. 2015 Nov;68(5):868-79.[Abstract]
13. Hicks D, Li CY. Management of macroscopic haematuria in the emergency department. Postgrad Med J. 2008 Oct;84(996):539-44.[Abstract]
14. Hansen RS, Biørn SH, Birk-Korch JB, et al. Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis. BJU Int. 2023 May;131(5):530-9.[Abstract][Full Text]
15. European Association of Urology. EAU guidelines on urological trauma. Mar 2025 [internet publication].[Full Text]
16. Tanagho EA, McAninch JW. Smith's general urology, 16th ed. New York, NY: McGraw-Hill; 2003.
17. Voelzke BB, Leddy L. The epidemiology of renal trauma. Transl Androl Urol. 2014 Jun;3(2):143-9.[Abstract][Full Text]
18. American Urological Association. Urotrauma (2020). Apr 2020 [internet publication].[Full Text]
19. Avey G, Blackmore CC, Wessells H, et al. Radiographic and clinical predictors of bladder rupture in blunt trauma patients with pelvic fracture. Acad Radiol. 2006 May;13(5):573-9.[Abstract]
20. Velazquez N, Fantus RJ, Fantus RJ, et al. Blunt trauma pelvic fracture-associated genitourinary and concomitant lower gastrointestinal injury: incidence, morbidity, and mortality. World J Urol. 2020 Jan;38(1):231-8.[Abstract]
21. Minotti B, Treglia G, Pascale M, et al. Prevalence of microhematuria in renal colic and urolithiasis: a systematic review and meta-analysis. BMC Urol. 2020 Aug 8;20(1):119.[Abstract][Full Text]
22. Macey MR, Raynor MC. Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review. Semin Intervent Radiol. 2016 Sep;33(3):217-23.[Abstract][Full Text]
23. Foley SJ, Soloman LZ, Wedderburn AW, et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol. 2000 Feb;163(2):496-8.[Abstract]
24. Nyman MA, Schwenk NM, Silverstein MD. Management of urinary retention: rapid versus gradual decompression and risk of complications. Mayo Clin Proc. 1997 Oct;72(10):951-6.[Abstract]
25. Wu MY, Chang JR, Lee YK, et al. The effect and safety of rapid and gradual urinary decompression in urine retention: a systematic review and meta-analysis. Medicina (Kaunas). 2022 Oct 13;58(10):1441.[Abstract][Full Text]
26. Subiela JD, Balla A, Bollo J, et al. Endovascular management of ureteroarterial fistula: single institution experience and systematic literature review. Vasc Endovascular Surg. 2018 Feb 26;52(4):275-86.[Abstract]
27. Jiang S, Wang Y, Zhang Z, et al. Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2018 Sep;143:288-300.[Abstract]
28. De Costa C, McLaughlin K, Noseworthy TW. Criteria for referring patients with renal disease for nephrology consultation: a review of the literature. J Nephrol. 2010 Jul-Aug;23(4):399-407.[Abstract]
29. Le Joncour A, Mesnard L, Hertig A, et al. Red urine, updated for the nephrologist: a case report. BMC Nephrol. 2018 Jun 8;19(1):133.[Abstract][Full Text]
30. Bhatt NR, Davis NF, Nolan WJ, et al. Incidence of visible hematuria among antithrombotic agents: a systematic review of over 175,000 patients. Urology. 2018 Apr;114:27-32.[Abstract]
31. Alamdarloo SM, Hashemi A, Hessami K, et al. Gross hematuria and placenta percreta: report of two cases and literature review. J Obstet Gynaecol Res. 2025 Jan;51(1):e16177.[Abstract]
32. Balan R, Radu VD, Giușcă SE, et al. A rare cause of massive hematuria: placenta percreta with bladder invasion. In Vivo. 2021 Nov-Dec;35(6):3633-9.[Abstract][Full Text]
33. Jauniaux E, Grønbeck L, Bunce C, et al. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019 Nov 12;9(11):e031193.[Abstract][Full Text]
34. Chorbińska J, Krajewski W, Zdrojowy R. Urological complications after radiation therapy-nothing ventured, nothing gained: a narrative review. Transl Cancer Res. 2021 Feb;10(2):1096-118.[Abstract][Full Text]
35. Leapman MS, Hall SJ, Stone NN, et al. Haematuria after prostate brachytherapy. BJU Int. 2013 Jan 29;111(8):E319-24.[Abstract][Full Text]
36. Sivakumaran P, Barros B, Antonio Dias VL, et al. A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the hospital for tropical diseases, London, United Kingdom. PLoS Negl Trop Dis. 2024 Dec;18(12):e0012699.[Abstract][Full Text]
37. Reichmann H. Real-world considerations regarding the use of the combination of levodopa, carbidopa, and entacapone (Stalevo(®) ) in Parkinson's disease. Eur J Neurol. 2023 Nov;30 Suppl 2:15-20.[Abstract][Full Text]
38. Moharamzadeh P, Ojaghihaghighi S, Amjadi M, et al. Effect of tranexamic acid on gross hematuria: a pilot randomized clinical trial study. Am J Emerg Med. 2017 Sep 9;35(12):1922-5.[Abstract]
39. O'Connor E, McVey A, Demkiw S, et al. Assessment and management of haematuria in the general practice setting. Aust J Gen Pract. 2021 Jul;50(7):467-71.[Abstract][Full Text]
40. Mariani AJ. The evaluation of adult hematuria: a clinical update. In: AUA update series 1998; volume XVII, lesson 24. Houston, TX: AUA Office of Education; 1998:185-92.
41. Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016 Apr 5;164(7):488-97.[Abstract][Full Text]
42. Moloney F, Murphy KP, Twomey M, et al. Haematuria: an imaging guide. Adv Urol. 2014;2014:414125.[Abstract][Full Text]
43. Ingelfinger JR. Hematuria in Adults. N Engl J Med. 2021 Jul 8;385(2):153-63.[Abstract]
44. Luciano RL, Perazella MA. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment. Drug Saf. 2015 Jan;38(1):55-64.[Abstract]
45. Sing RI, Singal RK. What is significant hematuria for the primary care physician? Can J Urol. 2012 Oct;19(suppl 1):36-41.[Abstract][Full Text]
46. American College of Radiology. ACR appropriateness criteria: pretreatment staging of urothelial cancer. 2024 [internet publication].[Full Text]
47. Centers for Disease Control and Prevention. Group a strep infection: clinical guidelines for post-streptococcal glomerulonephritis. Mar 2024 [internet publication].[Full Text]
48. Tasian GE, Jemielita T, Goldfarb DS, et al. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018 May 10;29(6):1731-40.[Abstract]
49. Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening. J Urol. 2023 Jul;210(1):46-53.[Abstract][Full Text]
50. Aneese AM, Manuballa V, Amin M, et al. Bladder urothelial carcinoma extending to rectal mucosa and presenting with rectal bleeding. World J Gastrointest Endosc. 2017 Jun 16;9(6):282-95.[Abstract][Full Text]
51. Barocas DA, Lotan Y, Matulewicz RS, et al. Updates to microhematuria: AUA/SUFU guideline (2025). J Urol. 2025 May;213(5):547-57.[Abstract][Full Text]
52. American College of Radiology. ACR appropriateness criteria: hematuria. 2019 [internet publication].[Full Text]
53. National Institute for Health and Care Excellence. Renal and ureteric stones: assessment and management. Jan 2019 [internet publication].[Full Text]
54. Kravchick S, Cherniavsky E, Verchovsky G, et al. Multidetector computed tomographic urography (MDCTU): its practical role in diagnosis of upper tract urothelial cancer in patients 50 years and older with different types of hematuria. Pathol Oncol Res. 2019 Jan;25(1):249-54.[Abstract]
55. Chlapoutakis K, Theocharopoulos N, Yarmenitis S, et al. Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol. 2010 Feb;73(2):334-8.[Abstract]
56. Wang LJ, Wong YC, Huang CC, et al. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol. 2010 Jan;183(1):48-55.[Abstract]
57. Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, et al; CT Urography Working Group of the European Society of Urogenital Radiology (ESUR). CT urography: definition, indications and techniques: a guideline for clinical practice. Eur Radiol. 2008 Jan;18(1):4-17.[Abstract]
58. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006 Apr;(100):S11-5.[Abstract]
59. American College of Radiology. ACR appropriateness criteria: hematuria - child. 2018 [internet publication].[Full Text]
60. Paner GP, Zehnder P, Amin AM, et al. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2011 Jan;18(1):79-89.[Abstract]
61. Silverman SG, Leyendecker JR, Amis ES Jr. What is the current role of CT urography and MR urography in the evaluation of the urinary tract? Radiology. 2009 Feb;250(2):309-23.[Abstract][Full Text]
62. Yecies T, Bandari J, Macleod L, et al. Evaluation of the risks and benefits of computed tomography urography for assessment of gross hematuria. Urology. 2019 Nov;133:40-5.[Abstract]
63. American College of Radiology. ACR appropriateness criteria: acute onset flank pain-suspicion of stone disease (Urolithiasis). 2023 [internet publication].[Full Text]
64. Sourtzis S, Thibeau JF, Damry N, et al. Radiologic investigation of renal colic: unenhanced helical CT compared with excretory urography. AJR Am J Roentgenol. 1999 Jun;172(6):1491-4.[Abstract]
65. Eisner BH, McQuaid JW, Hyams E, et al. Nephrolithiasis: what surgeons need to know. AJR Am J Roentgenol. 2011 Jun;196(6):1274-8.[Abstract][Full Text]
66. Willis SR, Ahmed HU, Moore CM, et al. Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis. BMJ Open. 2014 Jun 15;4(6):e004895.[Abstract][Full Text]
67. Drost FH, Osses DF, Nieboer D, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019 Apr 25;(4):CD012663.[Abstract][Full Text]
68. Powles T, Albiges L, Bex A, et al. Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024 Aug;35(8):692-706.[Abstract][Full Text]
69. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38.[Abstract]
70. Little P, Turner S, Rumsby K, et al. Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women. Br J Gen Pract. 2010 Jul;60(576):495-500.[Abstract][Full Text]
71. Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am. 1991 Mar;75(2):313-25.[Abstract]
72. European Association of Urology. Non-muscle-invasive bladder cancer. Mar 2025 [internet publication].[Full Text]
73. American Cancer Society. Screening tests for prostate cancer. Nov 2023 [internet publication].[Full Text]
74. National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management. December 2021 [internet publication].[Full Text]
75. Harada T, Abe T, Kato F, et al. Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma. BMC Urol. 2015 Sep 4;15:91.[Abstract][Full Text]
76. European Association of Urology. Urological trauma. Mar 2025 [internet publication].[Full Text]
77. The American Association for the Surgery of Trauma. Injury scoring scale; a resource for trauma care professionals. [internet publication].[Full Text]
78. Morey AF, McAninch JW, Tiller BK, et al. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol. 1999 Apr;161(4):1088-92.[Abstract]
79. Yeung LL, McDonald AA, Como JJ, et al. Management of blunt force bladder injuries: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2019 Feb;86(2):326-36.[Abstract][Full Text]
80. American College of Radiology. ACR appropriateness criteria: penetrating trauma - lower abdomen and pelvis. 2019 [internet publication].[Full Text]
81. James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021 Jan 12;5(1):280-300.[Abstract][Full Text]
82. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):e1-33.[Abstract][Full Text]
83. Nataraj G, Kurup S, Pandit A, et al. Correlation of fine needle aspiration cytology, smear and culture in tuberculous lymphadenitis: a prospective study. J Postgrad Med. 2002 Apr-Jun;48(2):113-6.[Abstract][Full Text]
84. Muneer A, Macrae B, Krishnamoorthy S, et al. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-98.[Abstract][Full Text]
85. Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002 Apr;121(4):1177-82.[Abstract]
86. Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985 Oct;79(4):467-78.[Abstract]
87. Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977 Apr;126(4):253-62.[Abstract][Full Text]
88. World Health Organization. WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection. Mar 2024 [internet publication].[Full Text]
89. Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420.[Abstract][Full Text]
90. Warshauer DM, McCarthy SM, Street L, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988 Nov;169(2):363-5.[Abstract]
91. Dong XQ, Shen Y, Xu LW, et al. Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma. Chin Med J (Engl). 2009 May 20;122(10):1179-83.[Abstract]
92. Heidenreich A, Ravery V; European Society of Oncological Urology. Preoperative imaging in renal cell cancer. World J Urol. 2004 Nov;22(5):307-15.[Abstract]
93. American Urological Association. Renal mass and localized renal cancer: evaluation, management, and follow up (2021). Jan 2021 [internet publication].[Full Text]
94. Silverman SG, Israel GM, Herts BR, et al. Management of the incidental renal mass. Radiology. 2008 Oct;249(1):16-31.[Abstract]